- $ROK (-2,25 %)
Revenue: USD 1.88 billion compared to analyst estimates of USD 1.89 billion (a year-on-year decline of 8.3% and a miss of 0.6%).
- Adjusted EPS (earnings per share): USD 1.83 compared to analyst estimates of USD 1.58 (a 16% outperformance).
- Adjusted EBITDA: $286 million compared to analyst estimates of $311.3 million (a margin of 15.2% and a miss of 8.1%).
- Management reaffirmed its guidance for the full year: Adjusted EPS of $9.20 (center).
- Operating margin: 17.1%, up from 13.7% in the same quarter last year.
- Free cash flow: $293 million, up from -$35.3 million in the same quarter last year.
- Organic sales: Decrease of 7.6% compared to the previous year (growth was 1% in the same quarter of the previous year)
Forecasts for the financial year 2025:
- The forecast sales growth range was reduced to (5.5)% to 0.5 which is based on a currency impact (FX) of around (1,5) % on turnover.
- The forecast range for organic sales growth was confirmed and stands at (4)% to 2.
- The forecast for diluted EPS (earnings per share) was confirmed and is in the range of 7.65 to 8.85 US dollars.
- The forecast for adjusted EPS was confirmed and is in the range of 8.60 to 9.80 US dollars.